Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Ranitidine-associated hallucinations.

W Price, L Coli, R D Brandstetter

European Journal of Clinical Pharmacology

|January 1, 1985

Summary

This summary is machine-generated.

Rare central nervous system adverse reactions, including hallucinations, were reported with ranitidine, a histamine H2-receptor antagonist. A 72-year-old female experienced visual and auditory hallucinations after starting ranitidine, with symptoms recurring upon rechallenge.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Treatment of Cholera by Subcutaneous Injections.

The Indian medical gazette·2017

Same author

Practice variation in late-preterm deliveries: a physician survey.

Journal of perinatology : official journal of the California Perinatal Association·2012

Same author

Effects of dietary betaine on milk yield and milk composition of mid-lactation Holstein dairy cows.

Journal of dairy science·2012

Same author

The cardiovascular burden of end-stage renal disease patients.

Minerva urologica e nefrologica = The Italian journal of urology and nephrology·2010

Same author

Comparison of noninvasive and central arterial blood pressure measurements in ELBW infants.

Journal of perinatology : official journal of the California Perinatal Association·2009

Same author

Mars and Prometheus: our clinical experience in acute chronic liver failure.

Transplantation proceedings·2008

Same journal

Efficacy and safety of Ensitrelvir in COVID-19 patients: a systematic review and meta-analysis with focus on viral clearance and RNA change.

European journal of clinical pharmacology·2026

Same journal

Comparing National Health Technology Assessment approaches and the new European Joint Clinical Assessment framework: The case of onco-hematological medicines.

European journal of clinical pharmacology·2026

Same journal

The efficacy of letrozole in the medical management of ectopic pregnancy: a systematic review and meta-analysis.

European journal of clinical pharmacology·2026

Same journal

Detection of intravenous drug physicochemical incompatibilities in clinical practice: e-Harvis compared to reference tools.

European journal of clinical pharmacology·2026

Same journal

Efficacy and safety of doravirine/islatravir for the treatment of HIV-1: a systematic review and meta-analysis of randomized controlled trials with GRADE assessment.

European journal of clinical pharmacology·2026

Same journal

Critical analysis of digitalis glycosides: declining use but increasing poison-center exposure cases for digitoxin.

European journal of clinical pharmacology·2026

See all related articles

Area of Science:

Pharmacology
Neuroscience
Clinical Medicine

Background:

Ranitidine is a widely used histamine H2-receptor antagonist.
Central nervous system (CNS) adverse reactions to ranitidine are uncommon.
Previous reports of ranitidine-associated CNS effects are limited.